5 million dollars in philippine pesos

Flag football scours nation with talent camps to uncover next wave of starsNone

Five New Yorkers have been charged with felony possession of stolen property, conspiracy and other related crimes, Queens District Attorney Melinda Katz said. The bust served as a reminder to shoppers as the holiday shopping season kicks off in earnest with Black Friday this week to make sure they are supporting legitimate establishments, she said. “When a deal seems too good to be true, I guarantee you, it’s too good to be true,” Katz said. Nationally, businesses lose roughly $100 billion and the average family pays $500 more a year because of the impact of organized retail theft, according to New York Gov. Kathy Hochul, who joined the district attorney and other law enforcement officials in Queens. The Democrat said the arrests also marked the first time anyone has been charged under a new criminal statute of fostering the sale of stolen goods that she recently signed into law to help crack down on retail theft. “This is real simple. We’ve had enough with criminals preying on our citizens,” Hochul said. “We are sick and tired of our citizens feeling they’re vulnerable to random crimes on the streets or these sophisticated organized crime rings. And we are coming after you.” Katz, the district attorney, said the group stole high-end makeup, perfume, beauty products, designer clothing and accessories from stores ranging from Macy’s to Victoria’s Secret, American Eagle, Sephora and Ulta Beauty over a roughly two-year period. The group’s leaders, married couple Cristopher Guzman and Yvelisse Guzman Batista, directed shoplifting crews to steal specific merchandise as they hit multiple stores in New York, New Jersey, Maryland and elsewhere along the East Coast, she said. They also paid truck drivers to divert products bound for retailers from manufacturer warehouses directly to locations under their control. The group, operating out of a home in Queens, then resold the merchandise online as well as at a brick-and-mortar boutique called Yvelisse Fashion in Santiago, a city in the Dominican Republic. Vince Scala, a lawyer for the couple and two of the other defendants, said his clients pleaded not guilty at their arraignment Saturday. They were released pending their next court date in January. “The charges are only a couple of days old, and I have not seen a single piece of evidence, discovery or police reports,” he said. “I look forward to reviewing the case at the appropriate time.” Tuesday’s announcement is part of a broader push from Hochul to counter Republican criticisms that Democrats in New York are soft on public safety issues, an issue that hurt her party in the 2022 midterm elections and has remained a consistent talking point for the GOP. Earlier this year, Hochul signed off on a handful of policies aimed at cracking down on retail theft, including increased criminal penalties for assaulting retail workers, new funding for law enforcement teams dedicated to retail theft and tax credits for businesses to install security cameras. She also approved policies that allow prosecutors to combine the value of stolen goods when filing larceny charges and made it easier to criminally charge third-party sellers of stolen goods. Retail theft has also been a concern elsewhere. Videos of brazen shoplifting crews rampaging through stores have been widely shared on social media, fueling widespread frustration that retail crime is rampant and unpunished. Earlier this month, California voters overwhelmingly passed a tough-on-crime ballot measure that makes shoplifting a felony for repeat offenders again. The measure partly rolled back a progressive law passed by voters a decade ago downgrading several nonviolent crimes to misdemeanors, including theft under $950 in value. Associated Press reporter Anthony Izaguirre in Albany contributed to this story. Follow Philip Marcelo at twitter.com/philmarcelo .‘Wicked’s’ Color Grading Is Intended to ‘Immerse People Into Oz, to Make It a Real Place,’ Says Director Jon M. Chu: If It Was ‘Fake,’ Then the Stakes That Elphaba and Glinda ‘Are Going Through Wouldn’t Feel Real’

Solid Tumor Testing Market to Grow at 5.9% CAGR, Projected to Hit USD 36.48 Billion by 2028LOS ANGELES — UCLA might have lost its chance at playing in a bowl game, but there’s still important outcomes at stake Saturday when the Bruins take on Fresno State. “I think the biggest thing here is you just want to go out and have a competitive spirit,” linebacker Carson Schwesinger said at the Bruins’ Tuesday practice. “You could say there’s not much to play for, and stuff like that, but I think, with this team too, you have a lot of competitive people, so you line it up at any time, we’re going to go out there and play our hardest.” There’s a collective desire to conclude a season laden with low points on a high one. There are also individual objectives on the line. For those with aspirations to play at the next level, it’s another chance to showcase talent and put quality reps on film. For the underclassmen hoping to step into the place of those departing, it’s another chance to prove they belong on the field and would flourish with additional snaps. And for others, like Schwesinger, rewarding accolades are up for grabs. On Monday, the redshirt junior was announced as one of five finalists for the Butkus Award, which is given annually to the nation’s best linebacker. Schwesinger has recorded double-digit tackles in eight of the Bruins’ last nine games, peaking with 17 in a loss at Washington on Nov. 15. He also snagged two interceptions the week before that in UCLA’s victory over Iowa. Schwesinger’s journey to an elite, game-wrecking defensive captain is a testament to his work ethic and his discipline to be able to keep his head down and not say much, as he put it. When he does speak, it’s rarely about himself. “It’s technically a one-person award,” he said about the Butkus Award, “but that’s a whole team award.” One of the individuals who helped him become a finalist for the Butkus Award has a chance at his own hardware. On Tuesday, Bruins defensive coordinator Ikaika Malloe was named one of the 65 nominees for the Broyles Award for the nation’s top assistant coach. “Coach Malloe is a great guy,” defensive end Oluwafemi Oladejo said Tuesday. “Yeah, he’s a good football coach, but he’s also a life coach.” On multiple occasions this season, Malloe has been overcome with emotion when expressing how much he wants his unit to improve. He’s now being recognized for those results. Oladejo, who played two seasons at Cal before transferring to UCLA in late 2022, is about to play his last college football game. In his final year of eligibility, he willingly shifted down from linebacker to the defensive line and will have another chance Saturday to showcase his versatility and dominance at his somewhat new position. With Oladejo and potentially Schwesinger, a redshirt junior, soon moving on from UCLA, their younger teammates have one final chance to prove why they should fill those vacated snaps. Defensive lineman Devin Aupiu and linebacker Jalen Woods look like prime candidates to make that jump. Aupiu, a redshirt junior, had his best game of the season against USC on Saturday, highlighted by a strip sack of Trojans quarterback Jayden Maiava. Woods had a season-high six tackles. “Last game, he played a lot of snaps and played really good,” Schwesinger said of Woods. “Same thing (this Saturday), just keep that momentum going.” Schwesinger nodded his head when asked if he was aware of the history of success Fresno State holds in its matchup with the Bruins. The Bulldogs have won the past four games between the programs, and while that last one came a year before Schwesinger arrived in Westwood, he knows how important it would be to be part of the group that returns to the win column. “We’re coming out ready to compete,” he said.

Jaylen Brown scores 29 points before Celtics beat Timberwolves 107-105 with late defensive standTHOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-announces-2025-first-quarter-dividend-302328180.html SOURCE Amgen

JACKSONVILLE, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Landstar System, Inc. (NASDAQ-LSTR), a technology-enabled, asset-light provider of integrated transportation management solutions delivering safe, specialized transportation logistics services, announced that on December 9, 2024, its Board of Directors has declared a special one-time cash dividend in the amount of $2.00 per share, payable on January 21, 2025, to stockholders of record as of the close of business on January 7, 2025. “Landstar’s strong balance sheet and free cash flow generation enable us to continue to return value to our stockholders,” said Landstar President and Chief Executive Officer Frank Lonegro. The Company purchased a total of 452,019 shares of its common stock at an aggregate cost of approximately $82.1 million during the first 11 months of its 2024 fiscal year. The Company also returned $120.5 million to stockholders in the form of cash dividends paid on shares of its common stock during the 2024 fiscal year. As previously reported, as of September 28, 2024, the Company had $531 million in cash and short-term investments. The Company intends to continue to use its available free cash flow to opportunistically purchase its stock under its stock purchase program. About Landstar: Landstar System, Inc., is a technology-enabled, asset-light provider of integrated transportation management solutions delivering safe, specialized transportation services to a broad range of customers utilizing a network of agents, third-party capacity providers and employees. Landstar transportation services companies are certified to ISO 9001:2015 quality management system standards and RC14001:2015 environmental, health, safety and security management system standards. Landstar System, Inc. is headquartered in Jacksonville, Florida. Its common stock trades on The NASDAQ Stock Market® under the symbol LSTR. Forward Looking Statements Disclaimer: The following is a “safe harbor” statement under the Private Securities Litigation Reform Act of 1995. Statements contained in this press release that are not based on historical facts are “forward-looking statements.” This press release contains forward-looking statements, such as statements which relate to Landstar’s business objectives, plans, strategies and expectations. Terms such as “anticipates,” “believes,” “estimates,” “intention,” “expects,” “plans,” “predicts,” “may,” “should,” “could,” “will,” the negative thereof and similar expressions are intended to identify forward-looking statements. Such statements are by nature subject to uncertainties and risks, including but not limited to: an increase in the frequency or severity of accidents or other claims; unfavorable development of existing accident claims; dependence on third party insurance companies; dependence on independent commission sales agents; dependence on third party capacity providers; the impact of the Russian conflict with Ukraine on the operations of certain independent commission sales agents, including the Company’s largest such agent by revenue in the 2023 fiscal year; decreased demand for transportation services; U.S. trade relationships; substantial industry competition; disruptions or failures in the Company’s computer systems; cyber and other information security incidents; dependence on key vendors; potential changes in taxes; status of independent contractors; regulatory and legislative changes; regulations focused on diesel emissions and other air quality matters; regulations requiring the purchase and use of zero-emission vehicles; intellectual property; and other operational, financial or legal risks or uncertainties detailed in Landstar’s Form 10-K for the 2023 fiscal year, described in Item 1A Risk Factors, and in other SEC filings from time to time. These risks and uncertainties could cause actual results or events to differ materially from historical results or those anticipated. Investors should not place undue reliance on such forward-looking statements, and the Company undertakes no obligation to publicly update or revise any forward-looking statements.Florida State continues torrid star with rout of UMassCHICAGO (AP) — Sam Darnold threw for 90 of his 330 yards in overtime to set up Parker Romo's game-ending 29-yard field goal , and the Minnesota Vikings outlasted the Chicago Bears 30-27 on Sunday after giving up 11 points in the final 22 seconds of regulation. Darnold threw two touchdown passes, Jordan Addison caught eight passes for a career-high 162 yards and a touchdown, and T.J. Hockenson had 114 yards receiving for the Vikings (9-2), who remained one game behind Detroit in the rugged NFC North. Caleb Williams threw for 340 yards and two touchdowns for the Bears (4-7), who lost their fifth straight and fell to 5-18 in one-possession games under coach Matt Eberflus, who is 14-31 in 2 1/2 seasons. Minnesota appeared to have the game in hand, leading 27-16 with 1:56 left after Romo kicked a 26-yard field goal. But the Bears weren’t finished. Deandre Carter made up for a muffed punt that led to a touchdown in the third quarter with a 55-yard kickoff return to the 40. Williams took it from there, capping an eight-play drive with a 1-yard touchdown pass to Keenan Allen. A 2-point conversion pass to DJ Moore made it 27-24 with 22 seconds remaining. The Bears recovered the onside kick and Williams hit Moore over the middle for a 27-yard gain to the 30 before spiking the ball. Cairo Santos made a 48-yard field goal as time expired. Chicago won the coin toss, but Williams was sacked for a 12-yard loss on second down, leading to a three-and-out. The Vikings took over at the 21, and Darnold led a 10-play drive, overcoming a sack and two penalties. Darnold connected with Hockenson for a 29-yard completion that put the ball on the 9. He took a knee and then Romo nailed the winner. Darnold surpassed his previous season high of 19 touchdown passes with a 2-yarder to Addison on the first play of the second quarter, and he made it 14-7 with a 5-yard score to Jalen Nailor late in the first half. He completed 22 of 34 passes. Aaron Jones ran for 106 yards and a score for the VIkings. Williams was 32 of 47 with a 103.1 passer rating in his second straight solid performance since Thomas Brown replaced the fired Shane Waldron as offensive coordinator. Moore caught seven passes for 106 yards and a touchdown, and Allen added 86 yards receiving and the late TD. Vikings: LB Ivan Pace Jr. (hamstring) and LT Cam Robinson (foot) left in the first quarter. ... Darnold missed two plays after he was hit by Gervon Dexter Sr. on a pass play with about 6 1/2 minutes. Vikings: Host Arizona next Sunday. Bears: Visit Detroit on Thanksgiving. AP NFL: https://apnews.com/hub/NFLAppeals court rejects emergency bid to ban transgender San Jose State volleyball player from championship tournament

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ASML Holding N.V. (ASML)

Alex Ovechkin is expected to miss 4 to 6 weeks with a broken left leg